Human memory CTL response specific for influenza a virus is broad and multispecific

Human Immunology

Volumn 61, Issue 5, 2000, Pages 438-452

  Gianfrani, Carmen ^a   Oseroff, Carla ^a   Sidney, John ^a   Chesnut, Robert W ^a   Sette, Alessandro ^a  

^a Epimmune   (United States)

Author keywords

CTL; HLA binding; Immunodominance; Vaccines; Viral infection

Indexed keywords

EPITOPE; HLA A ANTIGEN; HLA A2 ANTIGEN;

ADULT; ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; IMMUNIZATION; IMMUNOGENICITY; INFLUENZA VIRUS A; LYMPHOCYTE ACTIVATION; MEMORY CELL; MONONUCLEAR CELL; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

ANIMALS; EPITOPES; HLA-A ANTIGENS; HLA-A2 ANTIGEN; HLA-B7 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; MICE, TRANSGENIC; OLIGOPEPTIDES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0034087707     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(00)00105-1     Document Type: Article

References (70)

1. Bennink J.R., Yewdell J.W. Murine cytotoxic T lymphocyte recognition of individual influenza virus proteins high frequency of nonresponder MHC class I allele . J Exp Med. 168:1988;1935.
2. Gotch F., McMichael A., Smith G., Moss B. Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med. 165:1987;408.
3. Sercarz E.E., Lehmann P.V., Ametani A., Benichou G., Miller A., Moudgil K. Dominance and crypticity of T cell antigenic determinant. Annu Rev Immunol. 11:1993;729.
4. Yewdell J.W., Bennink J.R. Immunodominance in MHC class I-restricted T lymphocyte responses. Annu Rev Immunol. 17:1999;1.
5. Busch D.H., Pamer E.G. MHC class I/peptide stability implications for immunodominance, in vitro proliferation, and diversity of responding CTL . J Immunol. 160:1998;4441.
6. Buus S., Sette A., Colon S.M., Miles C., Grey H.M. The relation between major histocompatibility complex (MHC) restriction and the capacity of Ia to bind immunogenic peptides. Science. 235:1987;1353.
7. Chen W., Khilko S., Fecondo J., Margulies D.H., McCluskey J. Determinant selection of major histocompatibility complex class-I restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residue. J Exp Med. 180:1994;1471.
8. Deng Y., Yewdell J.W., Eisenlohr L.C., Bennink J.R. MHC affinity, peptide liberation, T cell repertoire, and immunodominance all contribute to the paucity of MHC class I-restricted peptides recognized by antiviral CTL. J Immunol. 158:1997;1507.
9. Parker K.C., Bednarek M.A., Coligan J.E. Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol. 152:1994;163.
10. Sette A., Vitiello A., Reherman B., et al. The relationship between class I binding affinity and immunogenicity of potential cytotixic T cell epitopes. J Immunol. 153:1994;5586.
11. b-restricted epitopes. J Immunol. 157:1996;5555.
12. Belz G.T., Altman J.D., Doherty P.C. Characteristics of virus-specific CD8(+) T cells in the liver during the control and resolution phases of influenza pneumonia. Proc Natl Acad Sci USA. 95:1998;13812.
13. Schulz M.P., Aichele P., Schneider R., Hansen T.H., Zinkernagel R.M., Herngartner H. Major histocompatibility complex binding and T cell recognition of a viral nonapeptide containing a minimal tetrapeptide. Eur J Immunol. 21:1991;1181.
14. Townsend A.R., Rothbard J., Gotch F.M., Bahadur G., Wraith D., McMichael A.J. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with a short synthetic peptides. Cell. 44:1986;959.
15. van der Most R.G., Sette A., Oseroff C., et al. Analysis of cytotoxic T cell responses to dominant and subdominant epitopes during acute and chronic lymphocytic choriomengitis virus infection. J Immunol. 157:1996;5543.
16. Vitiello A., Marchesini D., Furze J., Sherman L., Chesnut R.W. Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex. J Exp Med. 173:1991;1007.
17. Murali-Krishna K., Altman J.D., Suresh M., et al. Counting antigen-specific CD8 T cells. A reevaluation of bystander activation during viral infection. Immunity. 8:1998;177.
18. Sourdive D.J.D., Murali-Krishna K., Altman J.D., et al. Conserved T cell receptor repertoire in primary and memory CD8 T cell responses to an acute viral infection. J Exp Med. 188:1998;71.
19. Bednarek M.A., Sauma S.Y., Gammon M.C., et al. The minimum peptide epitope from the influenza virus matrix protein. Extra and intracellular loading of HLA-A2. J Immunol. 147:1991;4047.
20. Morrison J., Elvin J., Latron F., et al. Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA-A2 in its recognition by cytotoxic T lymphocytes. Eur J Immunol. 22:1992;903.
21. Gavioli R., Kurilla M.G., de Campos-Lima P.O., et al. Multiple HLA A11-restricted cytotoxic T-lymphocyte epitopes of different immunogenicities in the Epstein-Barr virus-encoded nuclear antigen 4. J Virol. 67:1993;1572.
22. Silinis S.L., Cross S.M., Elliot S.L., et al. Development of Epstein-Barr virus specific memory T cell receptor clonotypes in acute infectious mononucleosis. J Exp Med. 184:1996;1815.
23. Callan M.F.C., Tan L., Annels N., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med. 187:1998;1395.
24. Chisari F.V., Ferrari C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol. 13:1995;29.
25. McMichael A.J., Phillips R.E. Escape of human immunodeficiency virus from immune control. Annu Rev Immunol. 15:1997;271.
26. Rehermann B., Chang K.M., McHutchison J., et al. Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C virus in chronically infected patients. J Virol. 70:1996;7092.
27. Nayersina R., Fowler P., Giulhot S., et al. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection. J Immunol. 150:1993;4659.
28. Rehermann B., Fowler P., Sidney J., et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J Exp Med. 181:1995;1047.
29. Koziel M.J., Dudley D., Afdhal N., et al. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. J Clin Invest. 96:1995;2311.
30. Jameson J., Cruz J., Ennis F.A. Human cytotoxic T-lymphocytes repertoire to influenza A virus. J Virol. 72:1998;8682.
31. Rowland-Jones S.L., Dong T., Fowke K.R., et al. Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest. 102:1998;1758.
32. Ogg G.S., Jin X., Bonhoeffer S., et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 79:1998;2103.
33. Ruppert J., Sidney J., Celis E., Kubo R.T., Grey H.M., Sette A. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules. Cell. 74:1993;929.
34. Falk K., Rotzschke O., Takiguchi M., et al. Peptide motifs of HLA-A1, -A11, -A31, and -A33. Immunogenetics. 40:1994;238.
35. Kast W.M., Brandt R.M.P., Sidney J., et al. The role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins. J Immunol. 152:1994;3904.
36. Kubo R.T., Sette A., Grey H.M., et al. Definition of specific peptide motifs for four major HLA-A alleles. J Immunol. 152:1994;3913.
37. Huczko E.L., Bodnar W.M., Benjamin D., et al. Characteristics of endogenous peptides eluted from the class I MHC molecule HLA-B7 determined by mass spectrometry and computer modeling. J Immunol. 151:1993;2572.
38. Sidney J., del Guercio M.-F., Southwood S., et al. Several HLA alleles share overlapping peptide specificities. J Immunol. 154:1995;247.
39. Sidney J., Southwood S., del Guercio M.-F., et al. Specificity and degeneracy in peptide binding to HLA-B7-like class I molecules. J Immunol. 157:1996;3480.
40. Gulukota K., Sidney J., Sette A., De Lisi C. Two complementary methods for predicting peptides binding major histocompatibility complex molecules. J Mol Biol. 267:1997;1258.
41. Sidney J., Grey H.M., Southwood S., et al. Definition of an HLA-A3-like supermotif demonstrates the overlapping peptide binding repertoires of common HLA molecules. Hum Immunol. 45:1996;79.
42. Sette A., Sidney J., del Guercio M.-F., et al. Peptide binding to the most frequent HLA-A class I alleles measured by quantitative molecular binding assays. Mol Immunol. 31:1994;813.
43. Greenwood F., Hunter W., Glover J. The preparation of 131I-labeled human growth hormone of high specific radioactivity. Biochem J. 89:1963;114.
44. Milich D.R., Hughes J.L., McLachlan A., Thornton G.B., Moriarty A. Hepatitis B synthetic immunogen comprised of nucleocapsid T-cell sites and an envelope B-cell epitope. Proc Natl Acad Sci USA. 85:1989;1610.
45. Oseroff C., Sette A., Wentworth P., et al. Pools of lipidated HTL-CTL constructs prime for multiple HBV and HCV CTL epitope responses. Vaccine. 16:1998;823.
46. Wentworth P., Vitiello A., Sidney J., et al. Differences and similarities in the A2.1-restricted cytotoxic T cell repertoire in humans and human leukocyte antigen-transgenic mice. Eur J Immunol. 26:1996;97.
47. Livingston B., Crimi C., Grey H., et al. The Hepatitis B virus-specific CTL responses induced by lipopeptide vaccination are comparable to those elicited by acute viral infection. J Immunol. 159:1997;1383.
48. Oukka M., Manuguerra J.C., Livaditis N., et al. Protection against lethal viral infection by vaccination with nonimmunodominant peptides. J Immunol. 157:1996;3039.
49. Gotch F., McMichael A., Rothbard J. Recognition of influenza A matrix protein by HLA-A2-restricted cytotoxic T lymphocytes. Use of analogues to orientate the matrix peptide in the HLA-A2 binding site. J Exp Med. 168:1988;2045.
50. Celis E., Tsai V., Crimi C., et al. Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc Natl Acad Sci USA. 91:1994;2105.
51. Wentworth P.A., Celis E., Crimi C., et al. In vitro induction of primary antigen-specific CTL from peripheral blood mononuclear cells stimulated with synthetic peptides. Mol Immunol. 32:1995;603.
52. Bertoletti A., Chisari F.V., Penna A., et al. Definition of a minimal optimal cytotoxic T cell epitope within the hepatitis B virus nucleocapsid protein. J Virol. 7:1993;2376.
53. Zhang Q.J., Gavioli R., Klein G., Masucci M.G. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins. Proc Natl Acad Sci USA. 15:1993;2217.
54. Alexander J., Oseroff C., Sidney J., et al. Derivation of HLA-A11/Kb transgenic mice Functional CTL repertoire and human A11-restricted CTL epitopes . J Immunol. 159:1997;4753.
55. Webster R.G., Laver W.G., Air G.M., Shild G.C. Molecular mechanisms of variation in influenza viruses. Nature. 296:1982;115.
56. Murphy BR, Clements ML: The systemic and mucosal immune response of humans to influenza A virus. In Mestecky J, McGhee JR (eds.): Current Topics in Microbiology and Immunology. NewYork, Springer-Verlag, 1989.
57. Wentworth D.E., Thompson B.L., Xu X., et al. An influenza A (H1N1) virus, closely related to swine influenza virus, responsible for a fatal case of human influenza. J Virol. 68:1994;2051.
58. Sidney J., Grey H.M., Kubo R.T., Sette A. Practical, biochemical and evolutionary implication of the discovery of HLA class I supermotifs. Immunol Today. 17:1996;261.
59. Man S., Newberg M.H., Crotzer V.L., et al. Definition of a human T cell epitope from influenza A nonstructural protein 1 using HLA-A2.1 transgenic mice. Int Immunol. 7:1995;597.
60. DiBrino M., Tsuchida T., Turner R.V., Parker K.C., Coligan J.E., Biddison W.E. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs. J Immunol. 151:1993;5930.
61. Lehner P.J., Wang E.C.Y., Moss P.A.H., et al. Human HLA-A0201-restricted cytotoxic T lymphocyte recognition of influenza A is dominated by T cells bearing the Vβ17 gene segment. J Exp Med. 181:1995;79.
62. Martinon F., Gomard E., Hannoun C., Levy J.P. In vitro human cytotoxic T cell responses against influenza A virus can be induced and selected by synthetic peptides. Eur J Immunol. 20:1990;2171.
63. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V.S., McMichael A.J. Rapid effector function in CD8+ memory cells. J Exp Med. 15:1997;859.
64. Dunbar P.R., Ogg G.S., Chen J., Rust N., van der Bruggen P., Cerundolo V. Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood. Curr Biol. 8:1998;413.
65. Doolan D.L., Hoffman S.L., Southwood S., et al. Degenerate cytotoxic T cell epitopes from P. falciparum restricted by multiple HLA-A and HLA-B supertype alleles. Immunity. 7:1997;97.
66. Bertoni R., Sidney J., Fowler P., Chesnut R.W., Chisari F.V., Sette A. HLA-binding supermotifs predict broadly cross-reactive cytotoxic T lymphocyte responses in patients with acute hepatitis. J Clin Invest. 3:1997;503.
67. Momburg F., Roelse J., Howard J.C., Butcher G.W., Hammerling G.J., Neefjes J.J. Selectively of MHC-encoded peptide transporters from human, mouse and rat. Nature. 367:1994;648.
68. Bacik I., Cox J.H., Anderson R., Yewdell J.W., Bennink J.R. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino-but not carboxyl-terminus of the peptide. J Immunol. 15:1994;381.
69. Ishioka G, Fikes J, Hermanson G, Livingston B, Crimi C, Qin M, del Guercio M-F, Oseroff C, Dahlberg C, Alexander J, Chestnut R, Sette A: Utilization of MHC class I transgenic mice for development of minigene DNA vaccines encoding multiple HLA-restricted CTL epitopes. J Immunol 162:3915, 1999.
70. Thomson S.A., Sherrit M.A., Medveczky J., et al. Delivery of multiple CD8 cytotoxic T cell epitopes by DNA vaccination. J Immunol. 160:1998;1717.